These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16464105)

  • 1. De novo structure-based design of bisurea hosts for tetrahedral oxoanion guests.
    Bryantsev VS; Hay BP
    J Am Chem Soc; 2006 Feb; 128(6):2035-42. PubMed ID: 16464105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for improved host architectures: application of de novo structure-based design and high-throughput screening methods to identify optimal building blocks for multidentate ethers.
    Hay BP; Oliferenko AA; Uddin J; Zhang C; Firman TK
    J Am Chem Soc; 2005 Dec; 127(48):17043-53. PubMed ID: 16316251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo structure-based design of bis-amidoxime uranophiles.
    Vukovic S; Hay BP
    Inorg Chem; 2013 Jul; 52(13):7805-10. PubMed ID: 24004288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-Aided Molecular Design of Bis-phosphine Oxide Lanthanide Extractants.
    McCann BW; Silva ND; Windus TL; Gordon MS; Moyer BA; Bryantsev VS; Hay BP
    Inorg Chem; 2016 Jun; 55(12):5787-803. PubMed ID: 26883005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HostDesigner: a program for the de novo structure-based design of molecular receptors with binding sites that complement metal ion guests.
    Hay BP; Firman TK
    Inorg Chem; 2002 Oct; 41(21):5502-12. PubMed ID: 12377046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo structure-based design of anion receptors.
    Hay BP
    Chem Soc Rev; 2010 Oct; 39(10):3700-8. PubMed ID: 20820596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-based design of novel protein structures.
    Butterfoss GL; Kuhlman B
    Annu Rev Biophys Biomol Struct; 2006; 35():49-65. PubMed ID: 16689627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dinegative tetrahedral oxoanion complexation; structural and solution phase observations.
    Nelson J; Nieuwenhuyzen M; Pal I; Town RM
    Dalton Trans; 2004 Aug; (15):2303-8. PubMed ID: 15278122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.
    Firth-Clark S; Willems HM; Williams A; Harris W
    J Chem Inf Model; 2006; 46(2):642-7. PubMed ID: 16562994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flux (1): a virtual synthesis scheme for fragment-based de novo design.
    Fechner U; Schneider G
    J Chem Inf Model; 2006; 46(2):699-707. PubMed ID: 16563000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cavitands with introverted functionality stabilize tetrahedral intermediates.
    Hooley RJ; Restorp P; Iwasawa T; Rebek J
    J Am Chem Soc; 2007 Dec; 129(50):15639-43. PubMed ID: 18004852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design.
    Fechner U; Schneider G
    J Chem Inf Model; 2007; 47(2):656-67. PubMed ID: 17315990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
    Hartenfeller M; Proschak E; Schüller A; Schneider G
    Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel synthesis of chiral guanidinium receptors and their use in unfolding the energetics of enantiorecognition of chiral carboxylates.
    Jadhav VD; Schmidtchen FP
    J Org Chem; 2008 Feb; 73(3):1077-87. PubMed ID: 18161985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
    Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
    J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hybrid method for peptide identification using integer linear optimization, local database search, and quadrupole time-of-flight or OrbiTrap tandem mass spectrometry.
    DiMaggio PA; Floudas CA; Lu B; Yates JR
    J Proteome Res; 2008 Apr; 7(4):1584-93. PubMed ID: 18324765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo structure-based design of ion-pair triple-stranded helicates.
    Jia C; Hay BP; Custelcean R
    Inorg Chem; 2014 Apr; 53(7):3893-8. PubMed ID: 24670189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.